Vanda Pharmaceuticals (VNDA) Change in Acquisitions & Divestments (2010 - 2026)

Vanda Pharmaceuticals' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $30.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 65.26% year-over-year to $30.5 million; the TTM figure through Mar 2026 stood at $151.0 million (down 60.18% YoY), while the FY2025 annual figure was $208.2 million, down 40.85% from the prior year.
• Change in Acquisitions & Divestments came in at $30.5 million for Q1 2026 at Vanda Pharmaceuticals, down from $47.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $350.4 million in Q1 2023 to a low of $30.5 million in Q1 2026.
• A 5-year average of $93.7 million and a median of $82.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 289.0% in 2023 and plunged 82.73% in 2024, its largest moves.
• Vanda Pharmaceuticals' Change in Acquisitions & Divestments stood at $80.0 million in 2022, then surged by 40.14% to $112.1 million in 2023, then decreased by 13.83% to $96.6 million in 2024, then slumped by 51.35% to $47.0 million in 2025, then tumbled by 35.2% to $30.5 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $30.5 million, $47.0 million, and $35.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison